Publications
5530 Results
- Journal / Conference
- ASCO 5:197(#774)
- Year
- 1986
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
CHOP is curative in thirty percent of patients with diffuse largecell lymphoma: A twelve year Southwest Oncology Group followup.
- Journal / Conference
- ASCO 5:68(#265)
- Year
- 1986
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7436
Adjuvant chemotherapy for operable breast cancer with positiveaxillary nodes.
- Journal / Conference
- ASCO :#C-306
- Year
- 1986
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7510
The prognosis of exophytic large bowel tumors. Data from aSouthwest Oncology Group adjuvant study and the University of ArkansasMedical Science Campus.
- Journal / Conference
- ASCO :#C-266
- Year
- 1986
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7827
Adjuvant chemotherapy for poor prognosis estrogen receptornegative stage II, III breast cancer one year versus two years CMFVP.
- Journal / Conference
- ASCO 5:182(#713)
- Year
- 1986
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-7924
Age and patient outcome in limited small cell lung cancer. TheSouthwest Oncology Group(SWOG) experience.
- Journal / Conference
- ASCO 5:119(#462)
- Year
- 1986
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-7925
Randomized Phase III trial of doxorubin (D) + cyclophosphamide (C)+ BCG vs. DC + cisplatin (P) vs. DC +P + BCG in stages III & IVovarian cancer (OV CA).
- Journal / Conference
- ASCO 5:90(#380)
- Year
- 1986
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7990
Resected stage II testicular cancer: immediate adjuvantchemotherapy versus observation.
- Journal / Conference
- ASCO 5:99(#384)
- Year
- 1986
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7990
Toxicity of chemotherapy as adjuvant or salvage treatment in earlystage nonseminomatous testicular cancer (NSTC).
- Journal / Conference
- Am J Clin Oncol 9:103
- Year
- 1986
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7990
Resectable stage II testicular carcinoma: A randomized comparison of post-lymphadenectomy chemotherapy and initial observation - A Cooperative Intergroup study.
- Journal / Conference
- ASCO 5:80(#311)
- Year
- 1986
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8037